Generic_01 32by9 1920x540 Px 72dpi

Cam on CaMKII and heart failure research

At the DGK Annual Meeting 2023, Prof. Donald M. Bers, University of California, Davis, reports on his research on the pleitropic enzyme CaMKII, which is involved in various pathological processes in the body. He also talks about possible therapeutic approaches and other research topics he is working on.

Von: Romy Martínez

26.07.2023

Video interview: Heart failure research

with Prof. Donald M. Bers, University of California, Davis, School of Medicine, USA

Related Links

Prof. Mark Anderson, University of Chicago Medical Center, about his research on inhibitors of the protein kinase CaMKII and transatlantic research collaborations.

Link to the online portal of the 89th Annual Meeting

Here you will find the videos of the DGK Annual Meeting 2023.
Access is restricted to DGK members and conference attendees. You don't have a DGK membership yet? Learn more about the benefits of being a DGK member.

Das könnte Sie auch interessieren

Heart Failure 2026 | DECISION: Digoxin in niedriger Dosierung vs. Placebo bei Personen mit stabiler HFrEF/HFmrEF. Von Prof. J. Bauersachs.

Heart Failure 2026 | PRAISE-MR: ARNI (Sacubitril/Valsartan) vs. Standardtherapie bei HFpEF und atrialer funktioneller Mitralinsuffizienz. Von Prof. B. Aßmus.

Heart Failure 2026 | CONDUCT-AF: Vergleich von Reizleitungssystem- und biventrikulärem Pacing bei therapierefraktärem VHF. Von Prof. B. Aßmus.